Dariusz Bielicki

513 total citations
26 papers, 395 citations indexed

About

Dariusz Bielicki is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Dariusz Bielicki has authored 26 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 8 papers in Surgery. Recurrent topics in Dariusz Bielicki's work include Genetic factors in colorectal cancer (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (5 papers). Dariusz Bielicki is often cited by papers focused on Genetic factors in colorectal cancer (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (5 papers). Dariusz Bielicki collaborates with scholars based in Poland, United States and United Kingdom. Dariusz Bielicki's co-authors include Violetta Sulżyc‐Bielicka, Józef Kładny, Lidia Kołodziejczyk, Krzysztof Safranow, Wojciech Marlicz, Mariusz Kaczmarczyk, Michał Wasilewicz, B Gawrońska-Szklarz, W Domagała and Marek Droździk and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scandinavian Journal of Gastroenterology.

In The Last Decade

Dariusz Bielicki

25 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dariusz Bielicki Poland 12 128 104 99 81 78 26 395
Violetta Sulżyc‐Bielicka Poland 10 128 1.0× 91 0.9× 96 1.0× 45 0.6× 65 0.8× 22 336
William Guesdon France 11 118 0.9× 31 0.3× 105 1.1× 31 0.4× 100 1.3× 14 508
Masami Kuniyoshi Japan 9 48 0.4× 74 0.7× 34 0.3× 63 0.8× 56 0.7× 13 428
Ednéia Casagranda Bueno Brazil 12 156 1.2× 52 0.5× 28 0.3× 141 1.7× 30 0.4× 23 353
Junfeng Hao China 7 14 0.1× 43 0.4× 113 1.1× 25 0.3× 169 2.2× 10 441
Kathryn Chmura United States 10 12 0.1× 54 0.5× 151 1.5× 61 0.8× 85 1.1× 13 443
Patrice Céballos France 13 14 0.1× 193 1.9× 105 1.1× 18 0.2× 76 1.0× 47 574
María González‐Pons Puerto Rico 11 17 0.1× 163 1.6× 17 0.2× 93 1.1× 124 1.6× 29 489
P Cahen France 10 43 0.3× 49 0.5× 28 0.3× 19 0.2× 87 1.1× 26 327
Carl E. Roberts United States 11 36 0.3× 42 0.4× 87 0.9× 106 1.3× 128 1.6× 16 403

Countries citing papers authored by Dariusz Bielicki

Since Specialization
Citations

This map shows the geographic impact of Dariusz Bielicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dariusz Bielicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dariusz Bielicki more than expected).

Fields of papers citing papers by Dariusz Bielicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dariusz Bielicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dariusz Bielicki. The network helps show where Dariusz Bielicki may publish in the future.

Co-authorship network of co-authors of Dariusz Bielicki

This figure shows the co-authorship network connecting the top 25 collaborators of Dariusz Bielicki. A scholar is included among the top collaborators of Dariusz Bielicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dariusz Bielicki. Dariusz Bielicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sulżyc‐Bielicka, Violetta, Lidia Kołodziejczyk, Małgorzata Adamska, et al.. (2021). Colorectal cancer and Blastocystis sp. infection. Parasites & Vectors. 14(1). 200–200. 30 indexed citations
2.
Sulżyc‐Bielicka, Violetta, Lidia Kołodziejczyk, Dariusz Bielicki, et al.. (2018). Colorectal cancer and Cryptosporidium spp. infection. PLoS ONE. 13(4). e0195834–e0195834. 37 indexed citations
3.
Sulżyc‐Bielicka, Violetta, Paweł Domagała, Dariusz Bielicki, et al.. (2016). E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy. Pathology & Oncology Research. 22(3). 601–608. 8 indexed citations
4.
Wunsch, Ewa, Marta Klak, Urszula Wasik, et al.. (2015). Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR. Journal of Immunology Research. 2015. 1–8. 21 indexed citations
5.
Salkić, Nermin N., Grażyna Adler, Beata Karakiewicz, et al.. (2015). NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis. SHILAP Revista de lepidopterología. 15(2). 67–72. 6 indexed citations
6.
Białek, Andrzej, et al.. (2014). Treatment of large colorectal neoplasms by endoscopic submucosal dissection. European Journal of Gastroenterology & Hepatology. 26(6). 607–615. 32 indexed citations
7.
Sulżyc‐Bielicka, Violetta, Dariusz Bielicki, Agnieszka Bińczak‐Kuleta, et al.. (2013). Thymidylate Synthase Gene Polymorphism and Survival of Colorectal Cancer Patients Receiving Adjuvant 5-Fluorouracil. Genetic Testing and Molecular Biomarkers. 17(11). 799–806. 13 indexed citations
8.
Sulżyc‐Bielicka, Violetta, Paweł Domagała, Dariusz Bielicki, Krzysztof Safranow, & W Domagała. (2013). Thymidylate synthase expression and p21WAF1/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy. Cellular Oncology. 37(1). 17–28. 9 indexed citations
9.
Sulżyc‐Bielicka, Violetta, et al.. (2012). Prevalence of Cryptosporidium sp. In Patients with Colorectal Cancer. Polish Journal of Surgery. 84(7). 348–51. 36 indexed citations
10.
Sulżyc‐Bielicka, Violetta, Paweł Domagała, Elżbieta Urasińska, et al.. (2011). Expression of p21WAF1 in Astler–Coller stage B2 colorectal cancer is associated with survival benefit from 5FU-based adjuvant chemotherapy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 458(4). 431–438. 4 indexed citations
11.
Wasilewicz, Michał, et al.. (2010). Expression of cyclooxygenase-2 in colonic polyps. Polskie Archiwum Medycyny Wewnętrznej. 120(9). 313–320. 15 indexed citations
12.
Gawrońska-Szklarz, B, et al.. (2010). Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole. European Journal of Clinical Pharmacology. 66(7). 681–687. 32 indexed citations
13.
Wasilewicz, Michał, et al.. (2010). Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis. International Journal of Colorectal Disease. 25(9). 1079–1085. 41 indexed citations
14.
Sulżyc‐Bielicka, Violetta, Paweł Domagała, Maria Chosia, et al.. (2009). Nuclear thymidylate synthase expression in sporadic colorectal cancer depends on the site of the tumor. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 454(6). 695–702. 7 indexed citations
15.
Bielicki, Dariusz, et al.. (2007). [Serum anti-p53 antibodies in gastric cancer patients].. PubMed. 23(135). 192–5. 3 indexed citations
16.
Sulżyc‐Bielicka, Violetta, et al.. (2007). Cryptosporidiosis in Patients with Colorectal Cancer. Journal of Parasitology. 93(3). 722–724. 38 indexed citations
17.
Gawrońska-Szklarz, B, Józef Kładny, Grzegorz Kurzawski, et al.. (1999). Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps. Experimental and Toxicologic Pathology. 51(4-5). 321–325. 26 indexed citations
18.
Bielicki, Dariusz, et al.. (1995). PCNA defined proliferative activity of epithelial tumor cells in adenomas of the colon.. PubMed. 46(3). 151–4. 2 indexed citations
19.
Bielicki, Dariusz, et al.. (1993). PCNA/cyclin defined proliferative activity of epithelial cells in normal gastric mucosa and in chronic gastritis.. PubMed. 44(2). 75–8. 1 indexed citations
20.
Domagała, W, K Marlicz, Dariusz Bielicki, & Mary Osborn. (1993). Increased PCNA/cyclin index correlates with severity of duodenitis defined by histological criteria. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 422(5). 345–349. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Violetta Sulżyc‐Bielicka Breakdown of academic impact, for papers by William Guesdon Breakdown of academic impact, for papers by Masami Kuniyoshi Breakdown of academic impact, for papers by Ednéia Casagranda Bueno Breakdown of academic impact, for papers by Junfeng Hao Breakdown of academic impact, for papers by Kathryn Chmura Breakdown of academic impact, for papers by Patrice Céballos Breakdown of academic impact, for papers by María González‐Pons Breakdown of academic impact, for papers by P Cahen Breakdown of academic impact, for papers by Carl E. Roberts
Rankless by CCL
2026